NLRP3 and leukemia: Another important finding of this study was the higher expression of caspase 1 and NLRP3 in leukemia cells obtained at the time of disease relapse [61], which is consistent with other studies reporting that leukemia cells at relapse are more resistant to prednisolone and dexamethasone compared to leukemia cells at initial diagnosis [62].